Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Don J Diamond

Showing results (31-40 of 134) with videos related to

Pageof 14
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 20, 2010
Carbon nanotubes enhance CpG uptake and potentiate antiglioma immunityDongchang Zhao, Darya Alizadeh, Leying Zhang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 11, 2003
CTLA-4 blockade enhances the therapeutic effect of an attenuated poxvirus vaccine targeting p53 in an established murine tumor modelJonathan Espenschied, Jeffrey Lamont, Jeff Longmate, et al.
Viruses|December 28, 2021
Protection against Congenital CMV Infection Conferred by MVA-Vectored Subunit Vaccines Extends to a Second Pregnancy after Maternal Challenge with a Heterologous, Novel Strain VariantClaudia Fernández-Alarcón, Grace Buchholz, Heidi Contreras, et al.
Vaccine|May 27, 2014
Development of a novel, guinea pig-specific IFN-γ ELISPOT assay and characterization of guinea pig cytomegalovirus GP83-specific cellular immune responses following immunization with a modified vaccinia virus Ankara (MVA)-vectored GP83 vaccinePeter A Gillis, Nelmary Hernandez-Alvarado, Josephine S Gnanandarajah, et al.
Vaccines|November 20, 2019
MVA-Vectored Pentameric Complex (PC) and gB Vaccines Improve Pregnancy Outcome after Guinea Pig CMV Challenge, but Only gB Vaccine Reduces Vertical TransmissionHeidi Contreras, Felix Wussow, Claudia Fernández-Alarcón, et al.
Cancer Investigation|August 17, 2011
Recombinant modified vaccinia virus ankara (MVA) expressing wild-type human p53 induces specific antitumor CTL expansionGuang-Yun Song, Tumul Srivastava, Hidenobu Ishizaki, et al.
Cancer Research|August 4, 2004
Two distinct pathways of immuno-modulation improve potency of p53 immunization in rejecting established tumorsPirouz Daftarian, Guang-Yun Song, Saima Ali, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 4, 2006
Attenuated poxvirus expressing three immunodominant CMV antigens as a vaccine strategy for CMV infectionZhongde Wang, Corinna La Rosa, Simon F Lacey, et al.
Experimental Hematology|March 30, 2006
In vitro expansion of polyclonal T-cell subsets for adoptive immunotherapy by recombinant modified vaccinia AnkaraCorinna La Rosa, Zhongde Wang, Simon F Lacey, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 7, 2004
Human cytomegalovirus proteins pp65 and immediate early protein 1 are common targets for CD8+ T cell responses in children with congenital or postnatal human cytomegalovirus infectionLaura Gibson, Giampiero Piccinini, Daniele Lilleri, et al.
Pageof 14

Showing results (31-40 of 134) with videos related to

Sort By:
Pageof 14
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 20, 2010
Carbon nanotubes enhance CpG uptake and potentiate antiglioma immunityDongchang Zhao, Darya Alizadeh, Leying Zhang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 11, 2003
CTLA-4 blockade enhances the therapeutic effect of an attenuated poxvirus vaccine targeting p53 in an established murine tumor modelJonathan Espenschied, Jeffrey Lamont, Jeff Longmate, et al.
Viruses|December 28, 2021
Protection against Congenital CMV Infection Conferred by MVA-Vectored Subunit Vaccines Extends to a Second Pregnancy after Maternal Challenge with a Heterologous, Novel Strain VariantClaudia Fernández-Alarcón, Grace Buchholz, Heidi Contreras, et al.
Vaccine|May 27, 2014
Development of a novel, guinea pig-specific IFN-γ ELISPOT assay and characterization of guinea pig cytomegalovirus GP83-specific cellular immune responses following immunization with a modified vaccinia virus Ankara (MVA)-vectored GP83 vaccinePeter A Gillis, Nelmary Hernandez-Alvarado, Josephine S Gnanandarajah, et al.
Vaccines|November 20, 2019
MVA-Vectored Pentameric Complex (PC) and gB Vaccines Improve Pregnancy Outcome after Guinea Pig CMV Challenge, but Only gB Vaccine Reduces Vertical TransmissionHeidi Contreras, Felix Wussow, Claudia Fernández-Alarcón, et al.
Cancer Investigation|August 17, 2011
Recombinant modified vaccinia virus ankara (MVA) expressing wild-type human p53 induces specific antitumor CTL expansionGuang-Yun Song, Tumul Srivastava, Hidenobu Ishizaki, et al.
Cancer Research|August 4, 2004
Two distinct pathways of immuno-modulation improve potency of p53 immunization in rejecting established tumorsPirouz Daftarian, Guang-Yun Song, Saima Ali, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 4, 2006
Attenuated poxvirus expressing three immunodominant CMV antigens as a vaccine strategy for CMV infectionZhongde Wang, Corinna La Rosa, Simon F Lacey, et al.
Experimental Hematology|March 30, 2006
In vitro expansion of polyclonal T-cell subsets for adoptive immunotherapy by recombinant modified vaccinia AnkaraCorinna La Rosa, Zhongde Wang, Simon F Lacey, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 7, 2004
Human cytomegalovirus proteins pp65 and immediate early protein 1 are common targets for CD8+ T cell responses in children with congenital or postnatal human cytomegalovirus infectionLaura Gibson, Giampiero Piccinini, Daniele Lilleri, et al.
Pageof 14